cyclopentane has been researched along with Squamous Cell Carcinoma of Head and Neck in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, M; Hirofuji, T; Inoue, R; Jimi, E; Kajioka, S; Kato, K; Matsuda, M; Matsuzaki, E; Morita, H; Nakano, S; Takeuchi, H; Yoshimoto, S | 1 |
| Abbas, T; Allak, A; Benamar, M; Guessous, F; Jameson, MJ; Read, PW; Vanderdys, V | 1 |
| Dong, C; Jeong, LS; Jia, L; Kang, J; Li, L; Liang, Y; Liu, X; Liu, XK; Sun, S; Wang, X; Yan, Z; Yu, J; Zeng, MS; Zhang, W; Zhang, Y; Zhao, H; Zhong, Q | 1 |
| Brands, RC; El-Mesery, M; Hartmann, S; Kübler, AC; Müller-Richter, UDA; Scheurer, MJJ; Seher, A | 1 |
| Khuri, FR; Lonial, S; Sun, SY; Yue, P; Zhao, L | 1 |
5 other study(ies) available for cyclopentane and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.
Topics: Anoctamin-1; Antineoplastic Agents; Apoptosis; Bestrophins; Cell Line, Tumor; Cell Proliferation; Chloride Channels; Cyclopentanes; Gene Expression Regulation, Neoplastic; Humans; Indans; Ion Channel Gating; Membrane Proteins; Neoplasm Proteins; Protein Binding; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors.
Topics: Animals; Cyclopentanes; Female; Gene Silencing; Humans; Mice; Mice, Nude; Pyrimidines; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck; Transfection; Xenograft Model Antitumor Assays | 2018 |
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclopentanes; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; NEDD8 Protein; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyrimidines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2019 |
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy.
Topics: Amides; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fas Ligand Protein; Head and Neck Neoplasms; Humans; Hydrocortisone; Interleukin-8; NF-kappa B; Phenyl Ethers; Pyrimidines; Quinazolines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Thiophenes; Tumor Necrosis Factor-alpha | 2019 |
The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Head and Neck Neoplasms; Humans; Proteolysis; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Ubiquitin-Activating Enzymes; Ubiquitination; Up-Regulation | 2011 |